Real-World Treatment Patterns, Resource Utilization, and Cost of Care in Medicare Beneficiaries Newly Diagnosed with Acute Myeloid Leukemia and Treated with Venetoclax-Based Regimens

被引：0
|
作者：
Roth, Joshua A. [1 ]
D'Amico, Paul G. [1 ]
Russell-Smith, Alexander [2 ]
Purcell, Simon [3 ]
Donckels, Elizabeth [4 ]
Cappelleri, Joseph C. [5 ]
Ma, Jia [1 ]
Petrilla, Allison [4 ]
Kagan, Jerry [4 ]
Yu, Anthony [4 ]
机构：
[1] Pfizer, New York, NY USA
[2] Pfizer R&D UK Ltd, Sandwich, England
[3] Pfizer, Sandwich, England
[4] Inovalon, Bowie, MD USA
[5] Pfizer Inc, Groton, CT USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-198239
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5191 / 5192
页数：2
相关论文
共 50 条
  • [41] Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort study
    Guangyang Weng
    Jingya Huang
    Xin He
    Tingting Xue
    Linlin Yang
    Yu Zhang
    Guopan Yu
    Zhiqiang Sun
    Dongjun Lin
    Lan Deng
    Xinquan Liang
    Jie Xiao
    Hongyu Zhang
    Ziwen Guo
    Hua Jin
    Qifa Liu
    Xin Du
    Annals of Hematology, 2023, 102 : 3369 - 3381
  • [42] Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort study
    Weng, Guangyang
    Huang, Jingya
    He, Xin
    Xue, Tingting
    Yang, Linlin
    Zhang, Yu
    Yu, Guopan
    Sun, Zhiqiang
    Lin, Dongjun
    Deng, Lan
    Liang, Xinquan
    Xiao, Jie
    Zhang, Hongyu
    Guo, Ziwen
    Jin, Hua
    Liu, Qifa
    Du, Xin
    ANNALS OF HEMATOLOGY, 2023, 102 (12) : 3369 - 3381
  • [43] A Comparison of Acute Myeloid Leukemia (AML) Regimens: Hypomethylating Agents Combined with Ivosidenib or Venetoclax in Newly Diagnosed Patients with IDH1 Mutations: A Real-World Evidence Study
    Smith, B. Douglas
    Lachowiez, Curtis A.
    Ambinder, Alexander Joseph
    Binder, Gary
    Angiolillo, Anne
    Vestin, Assaf
    Paglia, Robert
    Potluri, Ravi
    Papademetriou, Eros
    LeBlanc, Thomas W.
    BLOOD, 2023, 142
  • [44] Real-World Health Care Resource Use and Costs Among Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax-Based and Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Second-Line Setting
    Fakhri, Bita
    Emechebe, Nnadozie
    Manzoor, Beenish S.
    Jawaid, Dureshahwar
    Alhasani, Hasan
    Edwards, Melanie
    Tuncer, Hande H.
    JCO ONCOLOGY PRACTICE, 2024, 20 (08)
  • [45] Real-world treatment patterns and healthcare resource use in patients with acute myeloid leukemia in Western Europe
    Kabra, Madhusudan
    Margotto, Luana
    Manuguid, Fil
    FUTURE ONCOLOGY, 2021, 17 (21) : 2769 - 2784
  • [46] HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG MEDICARE BENEFICIARIES INITIATING VENETOCLAX VS. BTKIS FOR RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: A REAL-WORLD STUDY
    Huntington, S.
    Manzoor, B. S.
    Jawaid, D.
    Puckett, J.
    Alhasani, H.
    Ravelo, A.
    Kamal-Bahl, S.
    Emechebe, N.
    Doshi, J. A.
    VALUE IN HEALTH, 2023, 26 (06) : S88 - S89
  • [47] Venetoclax in Combination with Azacitidine for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: A Canadian Cost-Utility Analysis
    Guinan, Kimberly
    Mathurin, Karine
    Au, Yunghan
    Schuh, Andre C.
    Bui, Cat N.
    Chai, Xinglei
    Lachaine, Jean
    CURRENT ONCOLOGY, 2022, 29 (10) : 7524 - 7536
  • [48] Real-World Efficacy and Hematologic Toxicity of Azacitidine and Venetoclax in a Cohort of Elderly Patients Unfit for Intensive Chemotherapy With Newly Diagnosed Acute Myeloid Leukemia
    Wysoglad, Hubert
    Krawczyk, Katarzyna
    Ochrem, Bogdan
    Madry, Krzysztof
    Drozd-Sokolowska, Joanna
    Sacha, Tomasz
    Basak, Grzegorz
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S294 - S294
  • [49] Outcomes with Real-World Use of Azacitidine and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Are Comparable to Long-Term Viale-a Results
    Shah, Zalak
    Boselli, Danielle
    Begley, Stephanie
    Bose, Rupali
    Pang, Yifan
    Sanikommu, Srinivasa Reddy
    Shah, Nilay A.
    Chojecki, Aleksander L.
    Knight, Thomas G.
    Ai, Jing
    Avalos, Belinda
    Copelan, Edward A.
    Grunwald, Michael R.
    Ragon, Brittany Knick
    BLOOD, 2024, 144 : 5194 - 5195
  • [50] Treatment Patterns and Adverse Events Among Elderly Newly Diagnosed Patients with Chronic Myeloid Leukemia: A Real-World Analysis of the Medicare Fee-for-Service Population
    Kota, Vamsi
    Jadhav, Kejal
    Wei, David
    Zhao, Yajin
    Singh, Sachinkumar
    Tomicki, Samantha
    Shao, Anran
    Shrestha, Swastina
    McDermott, Courtney
    Marquez, Gabriel
    Palli, Swetha
    Damon, Andrea
    Yang, Daisy
    Sadek, Islam
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S381 - S382
12345